Parkinson's disease prevalence in Fabry disease: A survey study

Recent research has suggested a possible link between Parkinson's disease (PD) and Fabry disease. To test this relationship, we administered a self-report and family history questionnaire to determine the prevalence of PD in Fabry disease patients and family members with likely pathogenic alpha...

Full description

Bibliographic Details
Main Authors: Adina H. Wise, Amy Yang, Hetanshi Naik, Chanan Stauffer, Natasha Zeid, Christopher Liong, Manisha Balwani, Robert J. Desnick, Roy N. Alcalay
Format: Article
Language:English
Published: Elsevier 2018-03-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
GLA
Online Access:http://www.sciencedirect.com/science/article/pii/S2214426917301544
id doaj-3a23630a49544daa97a18b3aea1b92b5
record_format Article
spelling doaj-3a23630a49544daa97a18b3aea1b92b52020-11-24T23:19:48ZengElsevierMolecular Genetics and Metabolism Reports2214-42692018-03-0114C273010.1016/j.ymgmr.2017.10.013Parkinson's disease prevalence in Fabry disease: A survey studyAdina H. Wise0Amy Yang1Hetanshi Naik2Chanan Stauffer3Natasha Zeid4Christopher Liong5Manisha Balwani6Robert J. Desnick7Roy N. Alcalay8Department of Neurology, Columbia University Medical Center, 710 W. 168th St., New York, NY 10032, United StatesDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Hospital, 1428 Madison Ave, Atran Building, 1st Floor, New York, NY 10029, United StatesDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Hospital, 1428 Madison Ave, Atran Building, 1st Floor, New York, NY 10029, United StatesDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Hospital, 1428 Madison Ave, Atran Building, 1st Floor, New York, NY 10029, United StatesDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Hospital, 1428 Madison Ave, Atran Building, 1st Floor, New York, NY 10029, United StatesDepartment of Neurology, Columbia University Medical Center, 710 W. 168th St., New York, NY 10032, United StatesDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Hospital, 1428 Madison Ave, Atran Building, 1st Floor, New York, NY 10029, United StatesDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Hospital, 1428 Madison Ave, Atran Building, 1st Floor, New York, NY 10029, United StatesDepartment of Neurology, Columbia University Medical Center, 710 W. 168th St., New York, NY 10032, United StatesRecent research has suggested a possible link between Parkinson's disease (PD) and Fabry disease. To test this relationship, we administered a self-report and family history questionnaire to determine the prevalence of PD in Fabry disease patients and family members with likely pathogenic alpha-galactosidase A (GLA) mutations. A total of 90 Fabry patients (77 from the online survey and 13 from the Icahn School of Medicine at Mount Sinai (ISMMS)) were included in the analysis. Two of the Fabry disease patients who completed the online survey were diagnosed with PD (2/90, 2.2%). Among probands older than 60, 8.3% (2/24) were diagnosed with PD. Using Kaplan Meier survival analysis, the age-specific risk of PD by age 70 was 11.1%. Family history was available on 72 Fabry families from the online study and 9 Fabry families from ISMMS. Among these 81 families, 6 (7.4%) had one first degree relative who fit the criteria for a conservative diagnosis of PD. The results of this study suggest that there may be an increased risk of developing PD in individuals with GLA mutations, but these findings should be interpreted with caution given the limitations of the study design.http://www.sciencedirect.com/science/article/pii/S2214426917301544Parkinson's diseaseFabry diseaseLysosomal storage disorderAlpha-galactosidase AGLA
collection DOAJ
language English
format Article
sources DOAJ
author Adina H. Wise
Amy Yang
Hetanshi Naik
Chanan Stauffer
Natasha Zeid
Christopher Liong
Manisha Balwani
Robert J. Desnick
Roy N. Alcalay
spellingShingle Adina H. Wise
Amy Yang
Hetanshi Naik
Chanan Stauffer
Natasha Zeid
Christopher Liong
Manisha Balwani
Robert J. Desnick
Roy N. Alcalay
Parkinson's disease prevalence in Fabry disease: A survey study
Molecular Genetics and Metabolism Reports
Parkinson's disease
Fabry disease
Lysosomal storage disorder
Alpha-galactosidase A
GLA
author_facet Adina H. Wise
Amy Yang
Hetanshi Naik
Chanan Stauffer
Natasha Zeid
Christopher Liong
Manisha Balwani
Robert J. Desnick
Roy N. Alcalay
author_sort Adina H. Wise
title Parkinson's disease prevalence in Fabry disease: A survey study
title_short Parkinson's disease prevalence in Fabry disease: A survey study
title_full Parkinson's disease prevalence in Fabry disease: A survey study
title_fullStr Parkinson's disease prevalence in Fabry disease: A survey study
title_full_unstemmed Parkinson's disease prevalence in Fabry disease: A survey study
title_sort parkinson's disease prevalence in fabry disease: a survey study
publisher Elsevier
series Molecular Genetics and Metabolism Reports
issn 2214-4269
publishDate 2018-03-01
description Recent research has suggested a possible link between Parkinson's disease (PD) and Fabry disease. To test this relationship, we administered a self-report and family history questionnaire to determine the prevalence of PD in Fabry disease patients and family members with likely pathogenic alpha-galactosidase A (GLA) mutations. A total of 90 Fabry patients (77 from the online survey and 13 from the Icahn School of Medicine at Mount Sinai (ISMMS)) were included in the analysis. Two of the Fabry disease patients who completed the online survey were diagnosed with PD (2/90, 2.2%). Among probands older than 60, 8.3% (2/24) were diagnosed with PD. Using Kaplan Meier survival analysis, the age-specific risk of PD by age 70 was 11.1%. Family history was available on 72 Fabry families from the online study and 9 Fabry families from ISMMS. Among these 81 families, 6 (7.4%) had one first degree relative who fit the criteria for a conservative diagnosis of PD. The results of this study suggest that there may be an increased risk of developing PD in individuals with GLA mutations, but these findings should be interpreted with caution given the limitations of the study design.
topic Parkinson's disease
Fabry disease
Lysosomal storage disorder
Alpha-galactosidase A
GLA
url http://www.sciencedirect.com/science/article/pii/S2214426917301544
work_keys_str_mv AT adinahwise parkinsonsdiseaseprevalenceinfabrydiseaseasurveystudy
AT amyyang parkinsonsdiseaseprevalenceinfabrydiseaseasurveystudy
AT hetanshinaik parkinsonsdiseaseprevalenceinfabrydiseaseasurveystudy
AT chananstauffer parkinsonsdiseaseprevalenceinfabrydiseaseasurveystudy
AT natashazeid parkinsonsdiseaseprevalenceinfabrydiseaseasurveystudy
AT christopherliong parkinsonsdiseaseprevalenceinfabrydiseaseasurveystudy
AT manishabalwani parkinsonsdiseaseprevalenceinfabrydiseaseasurveystudy
AT robertjdesnick parkinsonsdiseaseprevalenceinfabrydiseaseasurveystudy
AT roynalcalay parkinsonsdiseaseprevalenceinfabrydiseaseasurveystudy
_version_ 1725576782211448832